# Advances and Opportunities in Dual Chamber Injectables

Page: https://stenobird.com/podcast/pharmatalkradio-7131046/advances-and-opportunities-in-dual-chamber-injectables
Text version: https://stenobird.com/podcast/pharmatalkradio-7131046/advances-and-opportunities-in-dual-chamber-injectables.md
Podcast: [PharmaTalkRadio](https://stenobird.com/podcast/pharmatalkradio-7131046)
Published: 2026-05-05T14:45:09+00:00
Episode link: https://www.spreaker.com/episode/advances-and-opportunities-in-dual-chamber-injectables--71876825
Audio file: https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/71876825/podd_2025_dual_chamber_podcast.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/advances-and-opportunities-in-dual-chamber-injectables
Duration seconds: 1644

## Resource

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss progess in the development of liquid/liquid and liquid/lyo dual chamber systems. Specifically, they address: Overcoming primary container and autoinjector challenges for liquid-liquid delivery Improving upon dual chamber reconstitution devices Finding the right approach to navigate supply chain To learn more about the PODD Conference, please visit PODDConference.com .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/advances-and-opportunities-in-dual-chamber-injectables/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/pharmatalkradio-7131046/advances-and-opportunities-in-dual-chamber-injectables.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.